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Methods
Materials
Sprague-Dawley rats were purchased from Japan SLC Co Ltd. The standard culture medium was Dulbecco's Modified Eagle's Medium/Nutrient Mixture F-12 (DMEM/ F-12) from Gibco BRL. Recombinant IGF-1 was from Genzyme Techne. Anti-phospho-GSK-3 (Ser9) antibody, anti-phospho-Akt/PKB (Ser473) antibody and anti-Akt/ PKB antibody were from New England Biolabs. Anti-GSK-3 antibody was from Transduction Laboratories.
[ 3 H] leucine was from Amersham. Other materials and chemicals were obtained from commercial sources.
Cell Culture
A single-cell culture was prepared from neonatal rat hearts as described elsewhere. 18 Cardiomyocytes were distributed at a density of 6.4×10 4 cells per cm 2 . After seeding, the cells were cultured in DMEM/F-12 supplemented with 5% calf serum for 24 h and the culture medium was then changed to serum depleted DMEM/F-12.
Replication-Defective Recombinant Adenoviral Vectors
Adenoviral vectors encoding a constitutively active mutant of Akt (MyrAkt) by addition of a myristoylation signal at the NH2 terminus of the kinase and a dominant negative mutant of Akt (AktAA) (the substitution of Thr308 and Ser473 by Ala) 19 were kindly provided by Dr W. Ogawa (Division of Diabetes, Digestive and Kidney Disease, Department of Clinical Molecular Medicine, Kobe University Graduate School of Medicine, Japan). Adenoviral vectors encoding a dominant negative mutant of MEK1 (MAPKK) (MEK DN: the substitution of Asp208 in the kinase subdomain VII by Ala), an unphosphorylatable form of GSK-3 (GSK-3 S9A: the substitution of Ser9 by Ala) were prepared as described previously. 20 The cDNA encoding MEK DN 21 was kindly provided by Dr K. Okazaki (Biomolecular Engineering Research Institute, Osaka, Japan) and GSK-3 S9A by Dr H. Mukai (Biosignal Research Center, Kobe University).
Recombinant Adenoviral Gene Transfer
After 24 h of culture, cardiomyocytes were infected with recombinant adenoviruses expressing LacZ, MyrAkt, AktAA, MEK DN, or GSK-3 S9A (Ad LacZ, Ad MyrAkt, Ad AktAA, Ad MEK DN, or Ad GSK-3 S9A respectively), diluted in serum-depleted medium and incubated for 1 h. The viral suspension was removed and cardiomyocytes were cultured in serum-depleted medium for the following experiments.
Phosphorylation of GSK-3
After 72 h of culture, cardiomyocytes were stimulated with IGF-1 (100 ng/ml). Inhibitors were treated 30 min before stimulation. Whole cell extract was prepared as described previously. 22 Briefly, cardiomyocytes were washed twice in ice-cold phosphate buffered saline (PBS) and scraped into ice-cold lysis buffer containing 20 mmol/L HEPES (pH 7.7), 75 mmol/L NaCl, 2.5 mmol/L MgCl2, 0.1 mmol/L EDTA (pH 8.0), 20 mmol/L -glycerophosphate, 0.05% Triton X-100, 0.5 mmol/L dithiothreitol (DTT), 2 g/ml leupeptin, 0.1 mmol/L sodium orthovanadate, and 1 mmol/L phenylmethylsulfonyl fluoride (PMSF). Protein extract (30 g per lane) was subjected to western blot analysis using an anti-phospho-GSK-3 (Ser9) antibody and an anti-phospho-Akt/PKB (Ser473) antibody, which recognizes only proteins phosphorylated at each of the sites, or an anti-GSK-3 antibody and an anti-Akt/PKB antibody. Anti-rabbit IgG and anti-mouse IgG conjugated with horseradish peroxidase were used as the second antibodies. The immune complexes were visualized using the ECL Plus Western Blotting Detection System (Amersham International). The density of immunoreactive bands were analyzed using a NIH Image 1.55 software (National Institute of Health).
Amino Acid Incorporation into Proteins
The relative amount of protein synthesis was determined by assessing the incorporation of radioactivity into a trichloroacetic acid (TCA)-in-soluble fraction as described previously. 20 After adenoviral gene transfer, cardiomyocytes were incubated in DMEM/F-12 for 48 h until harvesting. Some of them were co-incubated with IGF-1 (100 ng/ml) 24 h before harvest. 18.5 MBq (0.5 mCi) /ml [ 3 H] leucine was added 2 h before harvest, then cells were quickly rinsed twice with ice-cold PBS and incubated for 30 min on ice with 5% TCA. After being washed twice with ice-cold 5% TCA, cells were solublized on 0.1% NaOH. Total TCA-insoluble radioactivity of each well was determined by scintillation counting.
Cellular Morphology
After adenoviral infection, cardiomyocytes were cultured in DMEM/F-12 with or without IGF-1 for 3 days. The cellular morphology was examined and photographed under a light microscope to determine the effects of Ad GSK-3 S9A infection. The number of cardiomyocytes in 5 random fields was counted. The surface area of 50 myocytes in each field was analyzed using NIH Image 1.55 software. and Akt phosphorylation at Ser473 (C) in cardiomyocytes. After 72 h of culture, cardiomyocytes were treated with IGF-1 at various concentrations (0.1-1,000 ng/ml, 5 min) (A) and for various periods (2-30 min) (B, C). Phosphorylation of GSK-3 and Akt was assessed by western blot analysis using an anti-phospho-specific GSK-3 (Ser9) antibody (A, B) and an anti-phospho-specific Akt (Ser473) (C). 
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Statistical Analysis
All values were expressed as means ± SEM. Experimental results were compared by one-way ANOVA and Bonferroni test for samples. Values were considered statistically significant at p<0.05.
Results
GSK-3 Phosphorylation by IGF-1 via PI-3 Kinase/Akt Pathway
Cardiomyocytes were treated with IGF-1 at various concentrations and for various periods to determine its effect on GSK-3 phosphorylation. Phosphorylation of GSK-3 was assessed by western blot analysis using an anti-phospho-specific GSK-3 (Ser9) antibody. IGF-1 phosphorylated GSK-3 in a dose dependent manner (Fig 1A) . Over the time course, the phosphorylation was detected within 2 min of the addition of IGF-1, reached a maximum at 2-5 min and then declined (Fig 1B) . We also determined Akt phosphorylation by IGF-1 using an antiphospho-specific Akt/PKB (Ser473) antibody. Akt phosphorylation had a similar time course to that of GSK-3 , with a peak at 2-5 min (Fig 1C) . Next, we examined the PI 3-kinase/Akt pathway using wortmannin (100 nmol/L), LY294002 (50 mmol/L) (inhibitors of PI 3-kinase), and adenoviral vectors, Ad MyrAkt (10 MOI) and Ad AktAA (1-100 MOI). Wortmannin and LY294002 inhibited the phosphorylation of GSK-3 by IGF-1 almost completely (Fig 2A) . Expression of MyrAkt increased GSK-3 phosphorylation in the absence of IGF-1 stimulation (Fig 2B) , whereas expression of AktAA repressed IGF-1-induced GSK-3 phosphorylation in a dose dependent manner (Fig 2C) .
Interaction Between the Akt/GSK-3 Pathway and the MAPK Cascade
Next, we examined the effect of MEK1 (MAPKK) on the Akt/GSK-3 pathway. Cardiomyocytes were infected with Ad MEK DN (10 MOI) 48 h before IGF-1 stimulation, and then the phosphorylation of Akt and GSK-3 was examined. Expression of Ad MEKDN extended the duration of Akt phosphorylation and there was no obvious decline (Fig 3A) . GSK-3 phosphorylation stimulated by IGF-1 was also sustained and the decline was inhibited by Ad MEKDN overexpression (Fig 3B) . This prolonged phosphorylation likely resulted from the extended Akt phosphorylation. In addition, pretreatment with PD98059 (an inhibitor of MEK) showed similar results to those for the MEK DN-treated experiments (data not shown). These results suggested that MEK negatively regulates or shortens the duration of Akt phosphorylation after IGF-1 stimulation.
Effect of Ad GSK-3 S9A on Amino Acid Incorporation
To examine the role of GSK-3 in myocardial hypertrophy, we evaluated amino acid incorporation. In cardiomyocytes infected with Ad lacZ, IGF-1 (100 ng/ml) induced approximately 40-50% increase in [ 3 H] leucine incorporation compared with that of unstimulated cells. Expression of GSK-3 S9A repressed the IGF-1-induced increase in amino acid incorporation (Fig 4) .
Cellular Morphology
We next investigated the role of GSK-3 on the morphological changes in cardiomyocytes. Cultured cardiomyocytes were infected with Ad LacZ or Ad GSK-3 S9A (all at 100 MOI), in culture medium with or without stimulation with IGF-1 (100 ng/ml) for 3 days. Fig 5 shows that in the absence of IGF-1 there was no increase in cell size. Under sustained IGF-1 stimulation, cardiomyocytes transfected by Ad LacZ demonstrated an increase in cell size, which was repressed in cardiomyocytes infected with Ad GSK-3 S9A. These results coincided with the finding that Ad GSK-3 S9A repressed amino acid incorporation under IGF-1 stimulation, and suggested that GSK-3 plays an important role in IGF-1-induced myocardial cell hypertrophy.
Discussion
We have shown that the hypertrophic signaling of GSK-3 induced by IGF-1 is regulated by both the PI 3-kinase/Akt/GSK-3 pathway and the MEK/Akt/GSK-3 pathway. Furthermore, overexpression of unphosphorylatable GSK-3 represses the hypertrophic effect of IGF-1 in vitro.
Various molecules induced by hypertrophic stimuli have been elucidated and the mechanism of cardiac hypertrophy is revealed to be very variable and complex. One hypertrophic stimulus activates multiple signal pathways, which interact with each other cooperatively or repressively. IGF-1 is well known to be implicated in not only energy metabolism, but also hypertrophic processes in cardiomyocytes in vitro and in vivo. It activates the Raf/MEK/MAPK pathway and the PI 3-kinase/Akt pathway.
The MAPK family plays pivotal roles in many cellular functions, such as cell proliferation and cell growth, in various types of cells. There are 3 MAPK sub-families, extracellular signal-related kinases (ERKs), c-Jun N-terminal kinases (JNKs) and p38-MAPK, all of which are involved in the hypertrophic responses of cardiomyocytes. [23] [24] [25] [26] [27] [28] [29] [30] [31] Numerous molecules downstream have been also discovered. In the present study, we concentrated on the signaling pathways of ERK induced by IGF-1. ERK is activated by serum growth factors, including insulin and IGF-1, and hypertrophic stimuli such as endothelin-1, phenylephrine, isoproterenol, leukemia inhibitory factor and mechanical stretch. When IGF-1 binds its receptors, Ras is activated through the mediation of Shc-or IRS-Grb2 with the Ras-specific GDP exchange factor, mSOS, and consequently Raf/MEK/ERK signaling ensues. Activated ERK phosphorylates the transcription factors that regulate hypertrophic genes. 32 The PI 3-kinase/Akt pathway, another important pathway induced by IGF-1, is considered to play essential roles in cell survival, such as suppression of apoptosis and repressing/promoting of metabolism. 33, 34 Recently, we and others reported that the PI 3-kinase/Akt pathway is implicated in cardiac hypertrophy; we showed that tumor necrosis factor-induces protein synthesis through PI 3-kinase/Akt pathway in neonatal cardiomyocytes. 35 Transgenic mice expressing the constitutively active mutant of PI 3-kinase 36 or Akt 37, 38 have cardiac hypertrophy, as assessed by heart weight and the size of the myocytes. Akt regulates nuclear transcription factors, including the cAMP-response element binding protein, E2F and nuclear factor-B (NF B), which promote hypertrophic gene expression. [39] [40] [41] However, the detailed mechanisms of signal transduction involving the PI 3-kinase/Akt pathway and the Raf/MEK/MAPK pathway, particularly the interaction between them, in the hypertrophic response remains unclear.
In the present study, we demonstrated an interaction between these 2 signaling pathways leading to GSK-3 , a major target of Akt, in IGF-1-stimulated neonatal rat cardiomyocytes. Both GSK-3 and Akt were phosphorylated by IGF-1 in a dose-dependent manner in cardiomyocytes. Wortmannin and LY294002, inhibitors of PI 3-kinase, inhibited the IGF-1 induced phosphorylation of GSK-3 and transfection of Ad MyrAkt increased the phosphorylation of GSK-3 . These results indicate the existence of a signal transduction pathway of PI 3-kinase/Akt/GSK-3 induced by IGF-1 in cardiomyocytes. However, phosphorylation of GSK-3 by IGF-1 was not completely inhibited by Ad AktAA. Therefore, it is possible that there are other GSK-3 phosphorylation pathways that detour Akt. Further investigation will be needed.
Next, we examined the interaction between the Raf/ MEK/MAPK pathway and the PI 3-kinase/Akt pathway. Transduction of Ad MEK DN extended the duration of Akt phosphorylation. Subsequently, GSK-3 -phosphorylation by IGF-1 was prolonged compared with IGF-1 stimulation only. These results suggested that MEK negatively regulates or shortens the duration of Akt phosphorylation. This result is in accordance with GSK-3 phosphorylation observed in 3T3 cells with epithelial growth factor (EGF) stimulation. 42 Those researchers showed that a MEK inhibitor, PD98059, shortened the duration of Akt activation and GSK-3 inhibition induced by EGF. To summarize these results, IGF-1-induced GSK-3 activation is regulated by at least 2 different signaling pathways, the PI 3-kinase/ Akt/GSK-3 and the MEK/Akt/GSK-3 .
We also examined the effect of overexpression of GSK-3 on cardiac hypertrophy in vitro. GSK-3 is currently considered to be a regulator of cardiac hypertrophy, because it is a major target of the PI 3-kinase/Akt pathway and its downstream targets, c-Jun and NF-ATs, regulate hypertrophic gene expression. [43] [44] [45] [46] In our experiments, the unphosphorylatable mutant of GSK-3 could inhibit the hypertrophic effects of IGF-1 on neonatal rat cardiomyocytes, which is in line with the results by Antos et al 47 and Sanbe et al. 48 Both groups generated transgenic mice expressing a constitutively active form of GSK-3 (constitutively unphosphorylated) under control of cardiac-specific promoters, and showed that these mice were physiologically normal under nonstressed conditions, but their hypertrophic responses to calcineurin activation, -adrenergic stimulation or pressure overload were very poor. Although the mechanism in detail is unknown, the phosphorylation of GSK-3 seems to play an important role in the hypertrophic signal elicited by hypertrophic stimuli that include IGF-1. Further investigation of the transduction mechanisms of GSK-3 will be needed because it may be one of the important proteins in the understanding of the pathology of cardiac hypertrophy.
